Saw an announcement on the main PPMD page about GSK recruiting for this phase 1 trial at Nationwide.  I'm confused.  


I thought there already was a non-ambulatory exon 51 skipping trial underway in Columbus.  Same thing, or is this a different drug / drug company?


Just wondering.  Figured someone here knows for sure....

Views: 138

Reply to This

Replies to This Discussion

The GSK trial in nonambulatory patients at Columbus is a pharmacokinetics study.  Single dose (may be placebo).



So, is this something new, Brian?  I knew someone doing what I thought was the same thing several months ago.

Reply to Discussion


Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service